Cosan S.A (CSAN3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 5.200 |
|---|---|
| 52-week range | 3.090 – 6.900 |
| Return, 1 month / 3 months | +33.7% / +33.3% |
| Return, 1 year / 3 years | −15.6% / −65.7% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 51.3% |
| Worst drawdown (1 year) | -54.0% |
| Average daily value traded | 144.78M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cosan S.A. is a Brazilian conglomerate based in São Paulo with businesses spanning energy and logistics. Through its operations it produces sugar and ethanol, distributes and markets fuels and lubricants, and takes part in natural gas and rail and port logistics. Its customers include fuel retailers, industrial users and agricultural and energy markets, and much of its activity is carried out through subsidiaries and joint ventures in Brazil and nearby countries.
Cosan S.A trades under the code CSAN3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cosan S.A (CSAN3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 5.200 on 23 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 865 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.6% and over the last three months it rose 33.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 12.4% | ||
| From 52-week high | -23.5% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 33.3% | ||
| 6-month return | 2.2% | ||
| 12-month return, skipping the last month | -36.9% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.0% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 144.78M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | +33.7% |
| 3 months | +33.3% |
| 6 months | +2.2% |
| 1 year | −15.6% |
| 3 years | −65.7% |
| 5 years | −72.5% |
Signals
| 50-day / 200-day average | 3.952 / 4.628 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.261 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jun 2024 | BRL 0.4515 |
| 18 May 2023 | BRL 0.4286 |
| 5 May 2022 | BRL 0.4281 |
| 14 Dec 2021 | BRL 0.3746 |
| 5 May 2021 | BRL 1.0306 |
| 3 Jun 2020 | BRL 1.4978 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.